Cannabis investment company MMJ Group Holdings
(ASX:MMJ) is pleased to announce that MediPharm Labs has been added to the Horizons Marijuana Life Sciences Index ETF.
MMJ owns approximately 4.4 million shares for a 4.5 per cent shareholding and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.
MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, cultivation, equipment and retail.
Shares in MMJ Group Holdings
(ASX:MMJ) are trading 2.17 per cent lower at $0.23.
